查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1980323

益生菌市场规模、份额、成长及全球产业分析：按类型和应用划分，区域洞察及2026-2034年预测

Probiotics Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 180 Pages | 商品交期: 请询问到货日

价格

益生菌市场成长要素

全球益生菌市场预计到2025年将达到731.3亿美元，从2026年的774亿美元成长到2034年的1,345亿美元，2026年至2034年的复合年增长率为7.15%。亚太地区在2025年将以48.35%的市场份额引领市场，这得益于可支配收入的增长、中产阶级的壮大以及益生菌强化食品和饮料消费量的增加。

益生菌是添加到食品、饮料、营养补充剂、动物饲料和化妆品中的活性微生物，旨在促进肠道菌丛平衡和整体健康。消费者对消化健康、免疫力和预防医学的日益关注，正显着加速全球对益生菌的需求。

市场动态

市场驱动因素

向功能性食品和饮料转型

消费者正从传统食品转向含有益生菌的机能性食品。不含乳製品、植物来源以及具有特定功效的益生菌产品正获得广泛认可。製造商们推出了一系列专注于特定菌株的产品，旨在解决消化器官系统问题、增强免疫力并促进整体健康。微生物组解决方案的持续创新正进一步推动市场成长。

市场限制因素

製造成本高，定价高

益生菌菌株的生产需要专门的基础设施、先进的发酵技术和临床检验。因此，生产成本高昂，含益生菌产品的价格也较高。开发中国家对价格的敏感度可能会限制这些产品的流通，尤其是在中低收入消费者群体中。

市场机会

电子商务平台扩张

线上零售通路的快速成长正在提升全球消费者获取益生菌产品的便利性。直接面向消费者的销售模式、个人化订阅模式以及精准的数位行销宣传活动，正助力製造商拓展基本客群。网路普及率的不断提高和消费者对便利性的需求，也为益生菌产品创造了强劲的成长机会。

市场趋势

个人化营养与先进配方

根据个人微生物组特征量身订製的个人化益生菌解决方案正成为产业发展的重要趋势。各公司正利用先进的生物技术和微生物组研究，开发客製化的营养补充品和机能饮料。低糖、成分简化的洁净标示产品也越来越受到注重健康的消费者的青睐。

細項分析

按原料

在市场细分中，它们被分为细菌、酵母和其他。

  • 以乳酸桿菌和双叉桿菌等经临床验证有效的菌株为主导的细菌类产品预计到2026年将引领市场，占据86.77%的市场份额。这些菌株因其对消化器官系统和免疫系统健康的益处而被广泛用于优格和膳食补充剂中。
  • 酵母市场预计将以 6.06% 的复合年增长率成长，这得益于其稳定性和互补的健康益处。

依产品类型

市场区隔分为食品饮料、保健品、动物饲料和化妆品。

  • 预计到 2026 年，食品饮料产业将占据市场主导地位，市占率达到 61.76%，这主要得益于对乳製品益生菌饮料、功能性谷物和非乳製品饮料的需求。
  • 受针对特定健康挑战和客製化营养解决方案的需求不断增长的推动，营养补充品市场预计将以 6.30% 的复合年增长率增长。
  • 随着其在饲料中的应用日益广泛，其应用范围也变得更加多样化。

透过使用

  • 到 2026 年，在预防医学意识不断增强的推动下，人类市场预计将占据最大的市场份额，达到 94.81%。
  • 预计动物领域将以 5.59% 的复合年增长率成长，这主要得益于畜牧业、水产养殖业和宠物营养领域使用量的增加。

按形式

  • 由于液态益生菌具有高生物利用度和快速吸收的特点，预计到 2026 年，液态益生菌将占据 53.54% 的市场份额。
  • 由于保质期长，且适用于补充剂和婴儿配方奶粉，预计粉状配方奶粉的年复合增长率将达到 6.90%。

透过分销管道

  • 由于品牌知名度高，且商品易于购买，超级市场和大卖场占据了最大的市场份额。
  • 线上零售/电子商务是成长最快的管道，预计年复合成长率将达到 7.47%，这主要得益于便利性和不断扩大的数位基础设施。

区域展望

亚太地区

预计到2025年，亚太地区市场规模将达到353.6亿美元，并继续维持其主导地位。中国和日本是主要贡献者，预计到2026年，两国市场规模将分别达到140.8亿美元和83亿美元。由于中产阶级需求的成长，印度市场也正在迅速崛起。

欧洲

预计到 2025 年，欧洲仍将是第二大市场，市场规模将达到 132.1 亿美元。在对发酵乳製品和肠道健康补充剂的强劲需求推动下，该地区预计将以 6.23% 的复合年增长率增长。

北美洲

预计到 2025 年，北美市场规模将达到 99.2 亿美元，而美国市场预计到 2026 年将达到 105 亿美元。人们对肠道健康和预防保健的高度重视正在推动市场需求。

南美洲、中东和非洲

预计到2025年，南美洲市场规模将达到68亿美元，主要得益于机能性食品日益普及。中东和非洲地区预计将保持稳定成长，这得益于人们对营养和预防医学日益增长的兴趣。

目录

第一章：引言

第二章执行摘要

第三章 市场动态

  • 市场驱动因素
  • 市场限制因素
  • 市场机会
  • 市场趋势

第四章：主要考虑因素

  • 母市场及相关市场概览
  • 供应链分析
  • 监管分析
  • 产业SWOT分析
  • 近期产业趋势：政策、併购、新产品发布

第五章：全球益生菌市场分析、洞察与预测（2026-2034年）

  • 主要发现与总结
  • 市场规模估算与预测
    • 依产品类型
      • 食品/饮料
      • 补充
      • 动物饲料
      • 化妆品
    • 来源
      • 细菌
      • 酵母菌
      • 其他的
    • 按形式
      • 粉末
    • 按最终用途
      • 人类
    • 透过分销管道
      • 超级市场和大卖场
    • 按地区
      • 北美洲
      • 欧洲
      • 亚太地区
      • 南美洲
      • 中东和非洲

第六章：北美益生菌市场分析、洞察与预测（2026-2034年）

  • 国家
    • 我们
    • 加拿大
    • 墨西哥

第七章：欧洲益生菌市场分析、洞察与预测（2026-2034年）

  • 国家
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 其他欧洲国家

第八章：亚太益生菌市场分析、洞察与预测（2026-2034年）

  • 国家
    • 中国
    • 印度
    • 日本
    • 东南亚
    • 澳洲
    • 其他亚太国家

第九章：南美益生菌市场分析、洞察与预测（2026-2034年）

  • 国家
    • 巴西
    • 阿根廷
    • 其他南美国家

第十章：中东和非洲益生菌市场分析、洞察与预测（2026-2034年）

  • 国家
    • UAE
    • 南非
    • 其他中东和非洲国家

第十一章：竞争矩阵

  • 主要企业采取的商务策略
  • 全球益生菌市场收入份额及排名分析：按主要生产商划分，2025 年

第十二章：公司简介

  • Yakult Honsha Co., Ltd.

第十三章 其他企业资料

  • Danone SA
  • Nestle SA
  • Chr. Hansen Holding A/S
  • DuPont Nutritona dn Biosciences
  • BioGaia AB
  • Probi AB
  • ADM
  • Kerry Group Plc
  • Meiji Holdings Co., Ltd.

第十四章 战略建议

第十五章附录

Product Code: FBI100083

Growth Factors of probiotics Market

The global probiotics market was valued at USD 73.13 billion in 2025 and is projected to grow from USD 77.40 billion in 2026 to USD 134.50 billion by 2034, exhibiting a CAGR of 7.15% during 2026-2034. Asia Pacific dominated the market with a 48.35% share in 2025, supported by rising disposable incomes, expanding middle-class populations, and growing consumption of probiotic-enriched foods and beverages.

Probiotics are live microorganisms incorporated into food, beverages, dietary supplements, animal feed, and cosmetics to promote gut microbiota balance and overall health. Increasing consumer awareness regarding digestive health, immunity, and preventive healthcare is significantly accelerating global demand.

Market Dynamics

Market Drivers

Shift Toward Functional Food and Beverages

Consumers are increasingly transitioning from traditional food products to functional foods enriched with probiotics. Dairy-free, plant-based, and targeted probiotic formulations are gaining strong traction. Manufacturers are introducing strain-specific products designed to address digestive disorders, immunity enhancement, and overall wellness. Continuous innovation in microbiome-based solutions is further strengthening market growth.

Market Restraints

High Production Costs and Premium Pricing

The manufacturing of probiotic strains requires specialized infrastructure, advanced fermentation technologies, and clinical validation. This results in higher production costs, leading to premium pricing of probiotic-enriched products. Price sensitivity in developing economies may restrict adoption, particularly among middle- and lower-income consumers.

Market Opportunities

Expansion of E-Commerce Platforms

Rapid growth in online retail channels is enhancing accessibility of probiotic products globally. Direct-to-consumer sales, personalized subscription models, and targeted digital marketing campaigns are enabling manufacturers to expand their customer base. Rising internet penetration and convenience-driven shopping behavior are creating strong growth opportunities.

Market Trends

Personalized Nutrition and Advanced Formulations

Personalized probiotic solutions tailored to individual microbiome profiles are emerging as a key industry trend. Companies are leveraging advanced biotechnology and microbiome research to develop customized dietary supplements and functional beverages. Clean-label products with reduced sugar and simplified ingredients are also gaining popularity among health-conscious consumers.

Segmentation Analysis

By Source

The market is segmented into bacteria, yeast, and others.

  • The bacteria segment is expected to dominate with 86.77% share in 2026, driven by clinically validated strains such as Lactobacillus and Bifidobacterium. These strains are widely used in yogurt and supplements for digestive and immune health benefits.
  • The yeast segment is projected to grow at a CAGR of 6.06%, supported by its stability and complementary health benefits.

By Product Type

The market is segmented into food & beverages, supplements, animal feed, and cosmetics.

  • Food & beverages are projected to dominate with a 61.76% share in 2026, driven by demand for dairy-based probiotic drinks, functional cereals, and non-dairy beverages.
  • Supplements are expected to grow at a CAGR of 6.30%, supported by increasing demand for targeted health solutions and customized nutrition.
  • Expanding use in animal feed is further diversifying applications.

By End Use

  • The human segment holds the largest share at 94.81% in 2026, driven by rising preventive healthcare awareness.
  • The animal segment is projected to grow at a CAGR of 5.59%, supported by increasing use in livestock, aquaculture, and pet nutrition.

By Form

  • Liquid probiotics account for 53.54% share in 2026, owing to higher bioavailability and faster absorption.
  • Powder form is projected to grow at a 6.90% CAGR, driven by longer shelf life and suitability for supplements and infant formula.

By Distribution Channel

  • Supermarkets & hypermarkets hold the largest share due to brand visibility and wide product availability.
  • Online retail/e-commerce is the fastest-growing channel, projected to grow at a CAGR of 7.47%, driven by convenience and expanding digital infrastructure.

Regional Outlook

Asia Pacific

Asia Pacific reached USD 35.36 billion in 2025, maintaining its dominant position. China and Japan are key contributors, with projected 2026 valuations of USD 14.08 billion and USD 8.30 billion, respectively. India is also emerging rapidly due to expanding middle-class demand.

Europe

Europe is valued at USD 13.21 billion in 2025 and remains the second-largest region. The region is projected to grow at a CAGR of 6.23%, supported by strong demand for fermented dairy products and gut health supplements.

North America

North America is estimated at USD 9.92 billion in 2025, with the U.S. market projected to reach USD 10.50 billion in 2026. High awareness of gut health and preventive wellness supports demand.

South America & Middle East & Africa

South America recorded USD 6.80 billion in 2025, driven by rising adoption of functional foods. The Middle East & Africa region is expected to grow steadily, supported by increasing focus on nutrition and preventive healthcare.

Competitive Landscape

The market features established multinational players and biotechnology firms. Key companies include Yakult Honsha Co., Ltd., Danone S.A., Nestle S.A., Chr. Hansen Holding A/S, DuPont Nutrition & Biosciences, BioGaia AB, Probi AB, ADM, Kerry Group Plc, and Meiji Holdings Co., Ltd. Companies are focusing on product portfolio expansion, strain innovation, and research & development to maintain competitive advantage.

Conclusion

The global probiotics market is set to expand from USD 73.13 billion in 2025 to USD 134.50 billion by 2034, driven by rising consumer awareness of digestive health, preventive healthcare trends, and functional food demand. While high production costs pose challenges, expanding e-commerce channels, personalized nutrition solutions, and ongoing strain innovation will continue to propel market growth. With Asia Pacific leading and developed markets steadily expanding, the probiotics industry is positioned for sustainable and long-term expansion through 2034.

Segmentation By Source, Product Type, Form, End Use, Distribution Channel, and Region

By Product Type Food and Beverages

  • Dairy-based products
  • Non-dairy based beverages
  • Cereals & snacks
  • Baked food
  • Frozen & confectionery
  • Ready-to-eat packaged meals

Supplements

  • Nutritional supplements
  • Specialty supplements
  • Infant formula

Animal Feed

Cosmetics

By Source Bacteria

  • Lactobacillus
  • Bifidobacterium
  • Others

Yeast

Others

By Form * Powder

  • Liquid
  • Encapsulated
  • Others

By End Use * Human

  • Animal

By Distribution Channel * Supermarkets & Hypermarkets

  • Pharmacies & Drug Stores
  • Health & Specialty Stores
  • Online Retail / E-commerce
  • Others

By Geography North America (By Source, Product Type, Form, End Use, Distribution Channel , and Country)

  • U.S. (By Form)
  • Canada (By Form)
  • Mexico (By Form)

Europe (By Source, Product Type, Form, End Use, Distribution Channel, and Country)

  • Germany (By Form)
  • U.K. (By Form)
  • Spain (By Form)
  • France (By Form)
  • Italy (By Form)
  • Rest of Europe (By Form)

Asia Pacific (By Source, Product Type, Form, End Use, Distribution Channel, and Country)

  • China (By Form)
  • India (By Form)
  • Australia (By Form)
  • Japan (By Form)
  • Southeast Asia (By Form)
  • Rest of the Asia Pacific (By Form)

South America (By Source, Product Type, Form, End Use, Distribution Channel , and Country)

  • Brazil (By Form)
  • Argentina (By Form)
  • Rest of South America (By Form)

Middle East and Africa (By Source, Product Type, Form, End Use, Distribution Channel and Country)

  • UAE (By Form)
  • South Africa (By Form)

Rest of the Middle East & Africa (By Form)

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Market Overview of Related/Parent Market
  • 4.2. Supply Chain Analysis
  • 4.3. Regulatory Analysis
  • 4.4. Industry SWOT Analysis
  • 4.5. Recent Industry Developments - Policies, Mergers & Acquisitions, and New Product Launches

5. Global Probiotics Market Analysis, Insights and Forecast, 2026-2034

  • 5.1. Key Findings / Summary
  • 5.2. Market Size Estimates and Forecast
    • 5.2.1. By Product Type (Value)
      • 5.2.1.1. Food and Beverages
        • 5.2.1.1.1. Dairy-based products
        • 5.2.1.1.2. Non-dairy based beverages
        • 5.2.1.1.3. Cereals & snacks
        • 5.2.1.1.4. Baked food
        • 5.2.1.1.5. Frozen & confectionery
        • 5.2.1.1.6. Ready-to-eat packaged meals
      • 5.2.1.2. Supplements
        • 5.2.1.2.1. Nutritional supplements
        • 5.2.1.2.2. Specialty supplements
        • 5.2.1.2.3. Infant formula
      • 5.2.1.3. Animal Feed
      • 5.2.1.4. Cosmetics
    • 5.2.2. By Source (Value)
      • 5.2.2.1. Bacteria
        • 5.2.2.1.1. Lactobacillus
        • 5.2.2.1.2. Bifidobacterium
        • 5.2.2.1.3. Others
      • 5.2.2.2. Yeast
      • 5.2.2.3. Others
    • 5.2.3. By Form (Value)
      • 5.2.3.1. Powder
        • 5.2.3.1.1. Liquid
        • 5.2.3.1.2. Encapsulated
        • 5.2.3.1.3. Others
    • 5.2.4. By End Use (Value)
      • 5.2.4.1. Human
        • 5.2.4.1.1. Animal
    • 5.2.5. By Distribution Channel (Value)
      • 5.2.5.1. Supermarkets & Hypermarkets
        • 5.2.5.1.1. Pharmacies & Drug Stores
        • 5.2.5.1.2. Health & Specialty Stores
        • 5.2.5.1.3. Online Retail / E-commerce
        • 5.2.5.1.4. Others
    • 5.2.6. By Region (Value)
      • 5.2.6.1. North America
      • 5.2.6.2. Europe
      • 5.2.6.3. Asia Pacific
      • 5.2.6.4. South America
      • 5.2.6.5. Middle East & Africa

6. North America Probiotics Market Analysis, Insights and Forecast, 2026-2034

  • 6.1. Key Findings / Summary
  • 6.2. Market Size Estimates and Forecast
    • 6.2.1. By Product Type (Value)
      • 6.2.1.1. Food and Beverages
        • 6.2.1.1.1. Dairy-based products
        • 6.2.1.1.2. Non-dairy based beverages
        • 6.2.1.1.3. Cereals & snacks
        • 6.2.1.1.4. Baked food
        • 6.2.1.1.5. Frozen & confectionery
        • 6.2.1.1.6. Ready-to-eat packaged meals
      • 6.2.1.2. Supplements
        • 6.2.1.2.1. Nutritional supplements
        • 6.2.1.2.2. Specialty supplements
        • 6.2.1.2.3. Infant formula
      • 6.2.1.3. Animal Feed
      • 6.2.1.4. Cosmetics
    • 6.2.2. By Source (Value)
      • 6.2.2.1. Bacteria
        • 6.2.2.1.1. Lactobacillus
        • 6.2.2.1.2. Bifidobacterium
        • 6.2.2.1.3. Others
      • 6.2.2.2. Yeast
      • 6.2.2.3. Others
    • 6.2.3. By Form (Value)
      • 6.2.3.1. Powder
        • 6.2.3.1.1. Liquid
        • 6.2.3.1.2. Encapsulated
        • 6.2.3.1.3. Others
    • 6.2.4. By End Use (Value)
      • 6.2.4.1. Human
        • 6.2.4.1.1. Animal
    • 6.2.5. By Distribution Channel (Value)
      • 6.2.5.1. Supermarkets & Hypermarkets
        • 6.2.5.1.1. Pharmacies & Drug Stores
        • 6.2.5.1.2. Health & Specialty Stores
        • 6.2.5.1.3. Online Retail / E-commerce
        • 6.2.5.1.4. Others
    • 6.2.6. By Country
      • 6.2.6.1. U.S.
        • 6.2.6.1.1. By Form (Value)
          • 6.2.6.1.1.1. Powder
          • 6.2.6.1.1.2. Liquid
          • 6.2.6.1.1.3. Encapsulated
          • 6.2.6.1.1.4. Others
      • 6.2.6.2. Canada
        • 6.2.6.2.1. By Form (Value)
          • 6.2.6.2.1.1. Powder
          • 6.2.6.2.1.2. Liquid
          • 6.2.6.2.1.3. Encapsulated
          • 6.2.6.2.1.4. Others
      • 6.2.6.3. Mexico
        • 6.2.6.3.1. By Form (Value)
          • 6.2.6.3.1.1. Powder
          • 6.2.6.3.1.2. Liquid
          • 6.2.6.3.1.3. Encapsulated
          • 6.2.6.3.1.4. Others

7. Europe Probiotics Market Analysis, Insights and Forecast, 2026-2034

  • 7.1. Key Findings / Summary
  • 7.2. Market Size Estimates and Forecast
    • 7.2.1. By Product Type (Value)
      • 7.2.1.1. Food and Beverages
        • 7.2.1.1.1. Dairy-based products
        • 7.2.1.1.2. Non-dairy based beverages
        • 7.2.1.1.3. Cereals & snacks
        • 7.2.1.1.4. Baked food
        • 7.2.1.1.5. Frozen & confectionery
        • 7.2.1.1.6. Ready-to-eat packaged meals
      • 7.2.1.2. Supplements
        • 7.2.1.2.1. Nutritional supplements
        • 7.2.1.2.2. Specialty supplements
        • 7.2.1.2.3. Infant formula
      • 7.2.1.3. Animal Feed
      • 7.2.1.4. Cosmetics
    • 7.2.2. By Source (Value)
      • 7.2.2.1. Bacteria
        • 7.2.2.1.1. Lactobacillus
        • 7.2.2.1.2. Bifidobacterium
        • 7.2.2.1.3. Others
      • 7.2.2.2. Yeast
      • 7.2.2.3. Others
    • 7.2.3. By Form (Value)
      • 7.2.3.1. Powder
        • 7.2.3.1.1. Liquid
        • 7.2.3.1.2. Encapsulated
        • 7.2.3.1.3. Others
    • 7.2.4. By End Use (Value)
      • 7.2.4.1. Human
        • 7.2.4.1.1. Animal
    • 7.2.5. By Distribution Channel (Value)
      • 7.2.5.1. Supermarkets & Hypermarkets
        • 7.2.5.1.1. Pharmacies & Drug Stores
        • 7.2.5.1.2. Health & Specialty Stores
        • 7.2.5.1.3. Online Retail / E-commerce
        • 7.2.5.1.4. Others
    • 7.2.6. By Country
      • 7.2.6.1. Germany
        • 7.2.6.1.1. By Form (Value)
          • 7.2.6.1.1.1. Powder
          • 7.2.6.1.1.2. Liquid
          • 7.2.6.1.1.3. Encapsulated
          • 7.2.6.1.1.4. Others
      • 7.2.6.2. U.K.
        • 7.2.6.2.1. By Form (Value)
          • 7.2.6.2.1.1. Powder
          • 7.2.6.2.1.2. Liquid
          • 7.2.6.2.1.3. Encapsulated
          • 7.2.6.2.1.4. Others
      • 7.2.6.3. France
        • 7.2.6.3.1. By Form (Value)
          • 7.2.6.3.1.1. Powder
          • 7.2.6.3.1.2. Liquid
          • 7.2.6.3.1.3. Encapsulated
          • 7.2.6.3.1.4. Others
      • 7.2.6.4. Italy
        • 7.2.6.4.1. By Form (Value)
          • 7.2.6.4.1.1. Powder
          • 7.2.6.4.1.2. Liquid
          • 7.2.6.4.1.3. Encapsulated
          • 7.2.6.4.1.4. Others
      • 7.2.6.5. Spain
        • 7.2.6.5.1. By Form (Value)
          • 7.2.6.5.1.1. Powder
          • 7.2.6.5.1.2. Liquid
          • 7.2.6.5.1.3. Encapsulated
          • 7.2.6.5.1.4. Others
      • 7.2.6.6. Rest of Europe
        • 7.2.6.6.1. By Form (Value)
          • 7.2.6.6.1.1. Powder
          • 7.2.6.6.1.2. Liquid
          • 7.2.6.6.1.3. Encapsulated
          • 7.2.6.6.1.4. Others

8. Asia Pacific Probiotics Market Analysis, Insights and Forecast, 2026-2034

  • 8.1. Key Findings / Summary
    • 8.1.1. By Product Type (Value)
      • 8.1.1.1. Food and Beverages
        • 8.1.1.1.1. Dairy-based products
        • 8.1.1.1.2. Non-dairy based beverages
        • 8.1.1.1.3. Cereals & snacks
        • 8.1.1.1.4. Baked food
        • 8.1.1.1.5. Frozen & confectionery
        • 8.1.1.1.6. Ready-to-eat packaged meals
      • 8.1.1.2. Supplements
        • 8.1.1.2.1. Nutritional supplements
        • 8.1.1.2.2. Specialty supplements
        • 8.1.1.2.3. Infant formula
      • 8.1.1.3. Animal Feed
      • 8.1.1.4. Cosmetics
    • 8.1.2. By Source (Value)
      • 8.1.2.1. Bacteria
        • 8.1.2.1.1. Lactobacillus
        • 8.1.2.1.2. Bifidobacterium
        • 8.1.2.1.3. Others
      • 8.1.2.2. Yeast
      • 8.1.2.3. Others
    • 8.1.3. By Form (Value)
      • 8.1.3.1. Powder
        • 8.1.3.1.1. Liquid
        • 8.1.3.1.2. Encapsulated
        • 8.1.3.1.3. Others
    • 8.1.4. By End Use (Value)
      • 8.1.4.1. Human
        • 8.1.4.1.1. Animal
    • 8.1.5. By Distribution Channel (Value)
      • 8.1.5.1. Supermarkets & Hypermarkets
        • 8.1.5.1.1. Pharmacies & Drug Stores
        • 8.1.5.1.2. Health & Specialty Stores
        • 8.1.5.1.3. Online Retail / E-commerce
        • 8.1.5.1.4. Others
    • 8.1.6. By Country
      • 8.1.6.1. China
        • 8.1.6.1.1. By Form (Value)
          • 8.1.6.1.1.1. Powder
          • 8.1.6.1.1.2. Liquid
          • 8.1.6.1.1.3. Encapsulated
          • 8.1.6.1.1.4. Others
      • 8.1.6.2. India
        • 8.1.6.2.1. By Form (Value)
          • 8.1.6.2.1.1. Powder
          • 8.1.6.2.1.2. Liquid
          • 8.1.6.2.1.3. Encapsulated
          • 8.1.6.2.1.4. Others
      • 8.1.6.3. Japan
        • 8.1.6.3.1. By Form (Value)
          • 8.1.6.3.1.1. Powder
          • 8.1.6.3.1.2. Liquid
          • 8.1.6.3.1.3. Encapsulated
          • 8.1.6.3.1.4. Others
      • 8.1.6.4. Southeast Asia
        • 8.1.6.4.1. By Form (Value)
          • 8.1.6.4.1.1. Powder
          • 8.1.6.4.1.2. Liquid
          • 8.1.6.4.1.3. Encapsulated
          • 8.1.6.4.1.4. Others
      • 8.1.6.5. Australia
        • 8.1.6.5.1. By Form (Value)
          • 8.1.6.5.1.1. Powder
          • 8.1.6.5.1.2. Liquid
          • 8.1.6.5.1.3. Encapsulated
          • 8.1.6.5.1.4. Others
      • 8.1.6.6. Rest of Asia Pacific
        • 8.1.6.6.1. By Form (Value)
          • 8.1.6.6.1.1. Powder
          • 8.1.6.6.1.2. Liquid
          • 8.1.6.6.1.3. Encapsulated
          • 8.1.6.6.1.4. Others

9. South America Probiotics Market Analysis, Insights and Forecast, 2026-2034

  • 9.1. By Product Type (Value)
    • 9.1.1. Food and Beverages
      • 9.1.1.1. Dairy-based products
        • 9.1.1.1.1. Non-dairy based beverages
        • 9.1.1.1.2. Cereals & snacks
        • 9.1.1.1.3. Baked food
        • 9.1.1.1.4. Frozen & confectionery
        • 9.1.1.1.5. Ready-to-eat packaged meals
      • 9.1.1.2. Supplements
        • 9.1.1.2.1. Nutritional supplements
        • 9.1.1.2.2. Specialty supplements
        • 9.1.1.2.3. Infant formula
      • 9.1.1.3. Animal Feed
      • 9.1.1.4. Cosmetics
    • 9.1.2. By Source (Value)
      • 9.1.2.1. Bacteria
        • 9.1.2.1.1. Lactobacillus
        • 9.1.2.1.2. Bifidobacterium
        • 9.1.2.1.3. Others
      • 9.1.2.2. Yeast
      • 9.1.2.3. Others
    • 9.1.3. By Form (Value)
      • 9.1.3.1. Powder
        • 9.1.3.1.1. Liquid
        • 9.1.3.1.2. Encapsulated
        • 9.1.3.1.3. Others
    • 9.1.4. By End Use (Value)
      • 9.1.4.1. Human
        • 9.1.4.1.1. Animal
    • 9.1.5. By Distribution Channel (Value)
      • 9.1.5.1. Supermarkets & Hypermarkets
        • 9.1.5.1.1. Pharmacies & Drug Stores
        • 9.1.5.1.2. Health & Specialty Stores
        • 9.1.5.1.3. Online Retail / E-commerce
        • 9.1.5.1.4. Others
    • 9.1.6. By Country
      • 9.1.6.1. Brazil
        • 9.1.6.1.1. By Form (Value)
          • 9.1.6.1.1.1. Powder
          • 9.1.6.1.1.2. Liquid
          • 9.1.6.1.1.3. Encapsulated
          • 9.1.6.1.1.4. Others
      • 9.1.6.2. Argentina
        • 9.1.6.2.1. By Form (Value)
          • 9.1.6.2.1.1. Powder
          • 9.1.6.2.1.2. Liquid
          • 9.1.6.2.1.3. Encapsulated
          • 9.1.6.2.1.4. Others
      • 9.1.6.3. Rest of South America
        • 9.1.6.3.1. By Form (Value)
          • 9.1.6.3.1.1. Powder
          • 9.1.6.3.1.2. Liquid
          • 9.1.6.3.1.3. Encapsulated
          • 9.1.6.3.1.4. Others

10. Middle East & Africa Probiotics Market Analysis, Insights and Forecast, 2026-2034

  • 10.1. Key Findings / Summary
    • 10.1.1. By Product Type (Value)
      • 10.1.1.1. Food and Beverages
        • 10.1.1.1.1. Dairy-based products
        • 10.1.1.1.2. Non-dairy based beverages
        • 10.1.1.1.3. Cereals & snacks
        • 10.1.1.1.4. Baked food
        • 10.1.1.1.5. Frozen & confectionery
        • 10.1.1.1.6. Ready-to-eat packaged meals
      • 10.1.1.2. Supplements
        • 10.1.1.2.1. Nutritional supplements
        • 10.1.1.2.2. Specialty supplements
        • 10.1.1.2.3. Infant formula
      • 10.1.1.3. Animal Feed
      • 10.1.1.4. Cosmetics
    • 10.1.2. By Source (Value)
      • 10.1.2.1. Bacteria
        • 10.1.2.1.1. Lactobacillus
        • 10.1.2.1.2. Bifidobacterium
        • 10.1.2.1.3. Others
      • 10.1.2.2. Yeast
      • 10.1.2.3. Others
    • 10.1.3. By Form (Value)
      • 10.1.3.1. Powder
        • 10.1.3.1.1. Liquid
        • 10.1.3.1.2. Encapsulated
        • 10.1.3.1.3. Others
    • 10.1.4. By End Use (Value)
      • 10.1.4.1. Human
        • 10.1.4.1.1. Animal
    • 10.1.5. By Distribution Channel (Value)
      • 10.1.5.1. Supermarkets & Hypermarkets
        • 10.1.5.1.1. Pharmacies & Drug Stores
        • 10.1.5.1.2. Health & Specialty Stores
        • 10.1.5.1.3. Online Retail / E-commerce
        • 10.1.5.1.4. Others
    • 10.1.6. By Country
      • 10.1.6.1. UAE
        • 10.1.6.1.1. By Form (Value)
          • 10.1.6.1.1.1. Powder
          • 10.1.6.1.1.2. Liquid
          • 10.1.6.1.1.3. Encapsulated
          • 10.1.6.1.1.4. Others
      • 10.1.6.2. South Africa
        • 10.1.6.2.1. By Form (Value)
          • 10.1.6.2.1.1. Powder
          • 10.1.6.2.1.2. Liquid
          • 10.1.6.2.1.3. Encapsulated
          • 10.1.6.2.1.4. Others
      • 10.1.6.3. Rest of MEA
        • 10.1.6.3.1. By Form (Value)
          • 10.1.6.3.1.1. Powder
          • 10.1.6.3.1.2. Liquid
          • 10.1.6.3.1.3. Encapsulated
          • 10.1.6.3.1.4. Others

11. Competitive Matrix

  • 11.1. Business Strategies Adopted by Leading Players
  • 11.2. Global Probiotics Market Revenue Share/Ranking Analysis, By Key Manufacturer, 2025

12. Company Profiles

  • 12.1. Yakult Honsha Co., Ltd.
    • 12.1.1. Overview
    • 12.1.2. Description
    • 12.1.3. Type Portfolio
    • 12.1.4. Financials (Data as available in public domain and/or on paid databases)
    • 12.1.5. Recent Developments

13. Similar in information has been provided for all the below companies

  • 13.1. Danone S.A.
  • 13.2. Nestle S.A.
  • 13.3. Chr. Hansen Holding A/S
  • 13.4. DuPont Nutritona dn Biosciences
  • 13.5. BioGaia AB
  • 13.6. Probi AB
  • 13.7. ADM
  • 13.8. Kerry Group Plc
  • 13.9. Meiji Holdings Co., Ltd.

14. Strategic Recommendations

15. Appendix

List of Tables

  • Table 1: Global Probiotics Market Value (USD Billion), by Product Type, 2021-2034
  • Table 2: Global Probiotics Market Value (USD Billion), by Source, 2021-2034
  • Table 3: Global Probiotics Market Value (USD Billion), by End Use, 2021-2034
  • Table 4: Global Probiotics Market Value (USD Billion), by Form, 2021-2034
  • Table 5: Global Probiotics Market Value (USD Billion), by Distribution Channel, 2021-2034
  • Table 6: Global Probiotics Market Value (USD Billion), by Region, 2021-2034
  • Table 7: North America Probiotics Market Value (USD Billion), by Product Type, 2021-2034
  • Table 8: North America Probiotics Market Value (USD Billion), by Source, 2021-2034
  • Table 9: North America Probiotics Market Value (USD Billion), by End Use, 2021-2034
  • Table 10: North America Probiotics Market Value (USD Billion), by Form, 2021-2034
  • Table 11: North America Probiotics Market Value (USD Billion), by Distribution Channel, 2021-2034
  • Table 12: North America Probiotics Market Value (USD Billion), by Country, 2021-2034
  • Table 13: U.S. Probiotics Market Value (USD Billion), by Form, 2021-2034
  • Table 14: Canada Probiotics Market Value (USD Billion), by Form, 2021-2034
  • Table 15: Mexico Probiotics Market Value (USD Billion), by Form, 2021-2034
  • Table 16: Europe Probiotics Market Value (USD Billion), by Product Type, 2021-2034
  • Table 17: Europe Probiotics Market Value (USD Billion), by Form, 2021-2034
  • Table 18: Europe Probiotics Market Value (USD Billion), by End Use, 2021-2034
  • Table 19: Europe Probiotics Market Value (USD Billion), by End User, 2021-2034
  • Table 20: Europe Probiotics Market Value (USD Billion), by Form, 2021-2034
  • Table 21: Europe Probiotics Market Value (USD Billion), by Country, 2021-2034
  • Table 22: Germany Probiotics Market Value (USD Billion), by Form, 2021-2034
  • Table 23: U.K. Probiotics Market Value (USD Billion), by Form, 2021-2034
  • Table 24: France Probiotics Market Value (USD Billion), by Form, 2021-2034
  • Table 25: Italy Probiotics Market Value (USD Billion), by Form, 2021-2034
  • Table 26: Spain Probiotics Market Value (USD Billion), by Form, 2021-2034
  • Table 27: Rest of Europe Probiotics Market Value (USD Billion), by Form, 2021-2034
  • Table 28: Asia Pacific Probiotics Market Value (USD Billion), by Source, 2021-2034
  • Table 29: Asia Pacific Probiotics Market Value (USD Billion), by End Use, 2021-2034
  • Table 30: Asia Pacific Probiotics Market Value (USD Billion), by Product Type, 2021-2034
  • Table 31: Asia Pacific Probiotics Market Value (USD Billion), by Form, 2021-2034
  • Table 32: Asia Pacific Probiotics Market Value (USD Billion), by Country, 2021-2034
  • Table 33: China Probiotics Market Value (USD Billion), by Form, 2021-2034
  • Table 34: India Probiotics Market Value (USD Billion), by Form, 2021-2034
  • Table 35: Japan Probiotics Market Value (USD Billion), by Form, 2021-2034
  • Table 36: Australia Probiotics Market Value (USD Billion), by Form, 2021-2034
  • Table 37: Rest of Asia Pacific Probiotics Market Value (USD Billion), by Form, 2021-2034
  • Table 38: South America Probiotics Market Value (USD Billion), by Product Type, 2021-2034
  • Table 39: South America Probiotics Market Value (USD Billion), by Form, 2021-2034
  • Table 40: South America Probiotics Market Value (USD Billion), by End Use, 2021-2034
  • Table 41: South America Probiotics Market Value (USD Billion), by Source, 2021-2034
  • Table 42: South America Probiotics Market Value (USD Billion), by Distribution Channel, 2021-2034
  • Table 43: South America Probiotics Market Value (USD Billion), by Country, 2021-2034
  • Table 44: Brazil Probiotics Market Value (USD Billion), by Form, 2021-2034
  • Table 45: Argentina Probiotics Market Value (USD Billion), by Form, 2021-2034
  • Table 46: Rest of South America Probiotics Market Value (USD Billion), by Form, 2021-2034
  • Table 47: Middle East and Africa Probiotics Market Value (USD Billion), by Product Type, 2021-2034
  • Table 48: Middle East and Africa Probiotics Market Value (USD Billion), by Form, 2021-2034
  • Table 49: Middle East and Africa Probiotics Market Value (USD Billion), by End Use, 2021-2034
  • Table 50: Middle East and Africa Probiotics Market Value (USD Billion), by Source, 2021-2034
  • Table 51: Middle East and Africa Probiotics Market Value (USD Billion), by Distribution Channel, 2021-2034
  • Table 52: Middle East and Africa Probiotics Market Value (USD Billion), by Country, 2021-2034
  • Table 53: UAE Probiotics Market Value (USD Billion), by Form, 2021-2034
  • Table 54: South Africa Probiotics Market Value (USD Billion), by Form, 2021-2034
  • Table 55: Rest of MEA Probiotics Market Value (USD Billion), by Form, 2021-2034
  • Table 56: Global Probiotics Market, Ranking Analysis (2025)

List of Figures

  • Figure 1: Global Probiotics Market (USD Billion), 2025 and 2034
  • Figure 2: Global Probiotics Market, By Product Type, 2025 and 2034, (USD Billion)
  • Figure 3: Global Probiotics Market, By Form, 2025 and 2034, (USD Billion)
  • Figure 4: Global Probiotics Market, By End Use, 2025 and 2034, (USD Billion)
  • Figure 5: Global Probiotics Market, By Source, 2025 and 2034, (USD Billion)
  • Figure 6: Global Probiotics Market, By Distribution Channel, 2025 and 2034, (USD Billion)
  • Figure 7: Global Probiotics Market Value (USD Billion), by Product Type, 2025 & 2034
  • Figure 8: Global Probiotics Market Value Share (%), by Product Type, 2025
  • Figure 9: Global Probiotics Market Value (USD Billion), by Form, 2025 & 2034
  • Figure 10: Global Probiotics Market Value Share (%), by Form, 2025
  • Figure 11: Global Probiotics Market Value (USD Billion), by End Use, 2025 & 2034
  • Figure 12: Global Probiotics Market Value Share (%), by End Use, 2025
  • Figure 13: Global Probiotics Market Value (USD Billion), by Source, 2025 & 2034
  • Figure 14: Global Probiotics Market Value Share (%), by Source, 2025
  • Figure 15: Global Probiotics Market Value (USD Billion), by Distribution Channel, 2025 & 2034
  • Figure 16: Global Probiotics Market Value Share (%), by Distribution Channel, 2025
  • Figure 17: Global Probiotics Market Value (USD Billion), By Region, 2025 & 2034
  • Figure 18: Global Probiotics Market Share (%), By Region, 2025
  • Figure 19: North America Probiotics Market Value (USD Billion), by Product Type, 2025 & 2034
  • Figure 20: North America Probiotics Market Value Share (%), by Product Type, 2025
  • Figure 21: North America Probiotics Market Value (USD Billion), by Form, 2025 & 2034
  • Figure 22: North America Probiotics Market Value Share (%), by Form, 2025
  • Figure 23: North America Probiotics Market Value (USD Billion), by End Use, 2025 & 2034
  • Figure 24: North America Probiotics Market Value Share (%), by End Use, 2025
  • Figure 25: North America Probiotics Market Value (USD Billion), by Source, 2025 & 2034
  • Figure 26: North America Probiotics Market Value Share (%), by Source, 2025
  • Figure 27: North America Probiotics Market Value (USD Billion), by Distribution Channel, 2025 & 2034
  • Figure 28: North America Probiotics Market Value Share (%), by Distribution Channel, 2025
  • Figure 29: North America Probiotics Market Value (USD Billion), by Country, 2025 & 2034
  • Figure 30: North America Probiotics Market Value Share (%), by Country, 2025
  • Figure 31: U.S. Probiotics Market Value (USD Billion), by Form, 2025 & 2034
  • Figure 32: U.S. Probiotics Market Value Share (%), by Form, 2025
  • Figure 33: Canada Probiotics Market Value (USD Billion), by Form, 2025 & 2034
  • Figure 34: Canada Probiotics Market Value Share (%), by Form, 2025
  • Figure 35: Mexico Probiotics Market Value (USD Billion), by Form, 2025 & 2034
  • Figure 36: Mexico Probiotics Market Value Share (%), by Form, 2025
  • Figure 37: Europe Probiotics Market Value (USD Billion), by Product Type, 2025 & 2034
  • Figure 38: Europe Probiotics Market Value Share (%), by Product Type, 2025
  • Figure 39: Europe Probiotics Market Value (USD Billion), by Form, 2025 & 2034
  • Figure 40: Europe Probiotics Market Value Share (%), by Form, 2025
  • Figure 41: Europe Probiotics Market Value (USD Billion), by End Use, 2025 & 2034
  • Figure 42: Europe Probiotics Market Value Share (%), by End Use, 2025
  • Figure 43: Europe Probiotics Market Value (USD Billion), by Source, 2025 & 2034
  • Figure 44: Europe Probiotics Market Value Share (%), by Source, 2025
  • Figure 45: Europe Probiotics Market Value (USD Billion), by Distribution Channel, 2025 & 2034
  • Figure 46: Europe Probiotics Market Value Share (%), by Distribution Channel, 2025
  • Figure 47: Europe Probiotics Market Value (USD Billion), by Country, 2025 & 2034
  • Figure 48: Europe Probiotics Market Share (%), by Country, 2025
  • Figure 49: Germany Probiotics Market Value (USD Billion), by Form, 2025 & 2034
  • Figure 50: Germany Probiotics Market Value Share (%), by Form, 2025
  • Figure 51: U.K. Probiotics Market Value (USD Billion), by Form, 2025 & 2034
  • Figure 52: U.K. Probiotics Market Value Share (%), by Form, 2025
  • Figure 53: France Probiotics Market Value (USD Billion), by Form, 2025 & 2034
  • Figure 54: France Probiotics Market Value Share (%), by Form, 2025
  • Figure 55: Italy Probiotics Market Value (USD Billion), by Form, 2025 & 2034
  • Figure 56: Italy Probiotics Market Value Share (%), by Form, 2025
  • Figure 57: Spain Probiotics Market Value (USD Billion), by Form, 2025 & 2034
  • Figure 58: Spain Probiotics Market Value Share (%), by Form, 2025
  • Figure 59: Rest of Europe Probiotics Market Value (USD Billion), by Form, 2025 & 2034
  • Figure 60: Rest of Europe Probiotics Market Value Share (%), by Form, 2025
  • Figure 61: Asia Pacific Probiotics Market Value (USD Billion), by Product Type, 2025 & 2034
  • Figure 62: Asia Pacific Probiotics Market Value Share (%), by Product Type, 2025
  • Figure 63: Asia Pacific Probiotics Market Value (USD Billion), by Form, 2025 & 2034
  • Figure 64: Asia Pacific Probiotics Market Value Share (%), by Form, 2025
  • Figure 65: Asia Pacific Probiotics Market Value (USD Billion), by End Use, 2025 & 2034
  • Figure 66: Asia Pacific Probiotics Market Value Share (%), by End Use, 2025
  • Figure 67: Asia Pacific Probiotics Market Value (USD Billion), by Source, 2025 & 2034
  • Figure 68: Asia Pacific Probiotics Market Value Share (%), by Source, 2025
  • Figure 69: Asia Pacific Probiotics Market Value (USD Billion), by Distribution Channel, 2025 & 2034
  • Figure 70: Asia Pacific Probiotics Market Value Share (%), by Distribution Channel, 2025
  • Figure 71: Asia Pacific Probiotics Market Value (USD Billion), by Country, 2025 & 2034
  • Figure 72: Asia Pacific Probiotics Market Value Share (%), by Country, 2025
  • Figure 73: China Probiotics Market Value (USD Billion), by Form, 2025 & 2034
  • Figure 74: China Probiotics Market Value Share (%), by Form, 2025
  • Figure 75: India Probiotics Market Value (USD Billion), by Form, 2025 & 2034
  • Figure 76: India Probiotics Market Value Share (%), by Form, 2025
  • Figure 77: Japan Probiotics Market Value (USD Billion), by Form, 2025 & 2034
  • Figure 78: Japan Probiotics Market Value Share (%), by Form, 2025
  • Figure 79: Australia Probiotics Market Value (USD Billion), by Form, 2025 & 2034
  • Figure 80: Australia Probiotics Market Value Share (%), by Form, 2025
  • Figure 81: Southeast Asia Probiotics Market Value (USD Billion), by Form, 2025 & 2034
  • Figure 82: Southeast Asia Probiotics Market Value Share (%), by Form, 2025
  • Figure 83: Rest of APAC Probiotics Market Value (USD Billion), by Form, 2025 & 2034
  • Figure 84: Rest of APAC Probiotics Market Value Share (%), by Form, 2025
  • Figure 85: South America Probiotics Market Value (USD Billion), by Product Type, 2025 & 2034
  • Figure 86: South America Probiotics Market Value Share (%), by Product Type, 2025
  • Figure 87: South America Probiotics Market Value (USD Billion), by Form, 2025 & 2034
  • Figure 88: South America Probiotics Market Value Share (%), by Form, 2025
  • Figure 89: South America Probiotics Market Value (USD Billion), by End Use, 2025 & 2034
  • Figure 90: South America Probiotics Market Value Share (%), by End Use, 2025
  • Figure 91: South America Probiotics Market Value (USD Billion), by Source, 2025 & 2034
  • Figure 92: South America Probiotics Market Value Share (%), by Source, 2025
  • Figure 93: South America Probiotics Market Value (USD Billion), by Distribution Channel, 2025 & 2034
  • Figure 94: South America Probiotics Market Value Share (%), by Distribution Channel, 2025
  • Figure 95: South America Probiotics Market Value (USD Billion), by Country, 2025 & 2034
  • Figure 96: South America Probiotics Market Value Share (%), by Country, 2025
  • Figure 97: Brazil Probiotics Market Value (USD Billion), by Form, 2025 & 2034
  • Figure 98: Brazil Probiotics Market Value Share (%), by Form, 2025
  • Figure 99: Argentina Probiotics Market Value (USD Billion), by Form, 2025 & 2034
  • Figure 100: Argentina Probiotics Market Value Share (%), by Form, 2025
  • Figure 101: Rest of South America Probiotics Market Value (USD Billion), by Form, 2025 & 2034
  • Figure 102: Rest of South America Probiotics Market Value Share (%), by Form, 2025
  • Figure 103: Middle East & Africa Probiotics Market Value (USD Billion), by Product Type, 2025 & 2034
  • Figure 104: Middle East & Africa Probiotics Market Value Share (%), by Product Type, 2025
  • Figure 105: Middle East & Africa Probiotics Market Value (USD Billion), by Form, 2025 & 2034
  • Figure 106: Middle East & Africa Probiotics Market Value Share (%), by Form, 2025
  • Figure 107: Middle East & Africa Probiotics Market Value (USD Billion), by End Use, 2025 & 2034
  • Figure 108: Middle East & Africa Probiotics Market Value Share (%), by End Use, 2025
  • Figure 109: Middle East & Africa Probiotics Market Value (USD Billion), by Source, 2025 & 2034
  • Figure 110: Middle East & Africa Probiotics Market Value Share (%), by Source, 2025
  • Figure 111: Middle East & Africa Probiotics Market Value (USD Billion), by Distribution Channel, 2025 & 2034
  • Figure 112: Middle East & Africa Probiotics Market Value Share (%), by Distribution Channel, 2025
  • Figure 113: Middle East & Africa Probiotics Market Value (USD Billion), by Country, 2025 & 2034
  • Figure 114: Middle East & Africa Probiotics Market Value Share (%), by Country, 2025
  • Figure 115: UAE Probiotics Market Value (USD Billion), by Form, 2025 & 2034
  • Figure 116: UAE Probiotics Market Value Share (%), by Form, 2025
  • Figure 117: South Africa Probiotics Market Value (USD Billion), by Form, 2025 & 2034
  • Figure 118: South Africa Probiotics Market Value Share (%), by Form, 2025
  • Figure 119: Rest of South America Probiotics Market Value (USD Billion), by Form, 2025 & 2034
  • Figure 120: Rest of South America Probiotics Market Value Share (%), by Form, 2025
  • Figure 121: Global Probiotics Market, Most Adopted Strategies, 2021-2026